Cosmetic Peptide Manufacturing Market

Cosmetic Peptide Manufacturing Market Outlook from 2024 to 2034

The global cosmetic peptide manufacturing market is expected to grow at a CAGR of 5.4% through 2034. The market value is projected to increase from USD 244.2 million in 2024 to USD 411.9 million by 2034. The cosmetic peptide manufacturing market was valued at USD 233.7 million in 2023.

Attributes	Details
Cosmetic Peptide Manufacturing Market Size, 2023	USD 233.7 Million
Estimated Market Size, 2024	USD 244.2 Million
Projected Market Value, 2034	USD 411.9 Million
Value-based CAGR (2024 to 2034)	5.4%

Key Market Trends

Consumers are shifting toward a holistic approach to beauty, valuing products that not only provide immediate results but also support the skin's natural processes. Peptides, with their diverse benefits, fit well into this approach by promoting skin resilience from within.

Peptides can be tailored to address specific skin concerns, such as hyperpigmentation, acne, and inflammation. The emerging trend toward targeted solutions aligns with consumers seeking products that effectively address their unique needs.

Historical Analysis of the Cosmetic Peptide Manufacturing Market Compared to Growth Prospects

The global cosmetic peptide manufacturing market recorded a CAGR of 3.2% from 2019 to 2023.

Historical Market Size, 2023	USD 233.7 Million
Historical CAGR, 2019 to 2023	3.2%

Consumers are increasingly looking for safe and effective skin care-regime-based solutions, with high efficacy, as an alternative to procedure-based treatments for all ages to address their personal skin needs. Thus, to meet the rising personal care demand, key players are constantly researching and developing cosmetic solutions that are expected to be highly accepted by consumers.

In January 2022, BASF introduced Peptovitae™, an innovative series featuring four patented peptides that signify a groundbreaking advancement in scientifically formulated biomimetic peptides. This Peptovitae™ collection stands out by addressing a broader spectrum of skin concerns beyond the conventional scope associated with peptide use. Developed by BASF's Care Creations®, these new bioactives cater to various personal care skin needs. They target aging signs with Peptovitae™ Matrix, and enhance skin brightness with Peptovitae™ Bright. Along with this, they, provide relief for dry and itchy skin with Peptovitae™ Derma, and offer a calming and moisturizing effect with Peptovitae™ Clear. Through this initiative, BASF aims to empower consumers of all ages to realize their beauty aspirations.

Using these peptides as active ingredients, consumers can have access to products with proven efficacy. This is expected to boost the demand for cosmetic formulations, which in turn is expected to boost the cosmetic peptide manufacturing market’s growth in the coming years.

Opportunities in the Cosmetic Peptide Manufacturing Market

The growing popularity of derma cosmetic products that are based on natural ingredients is fueling growth in the market. This can be attributed to their ability to deliver solutions specific to consumers’ unique needs like microbiome approaches. Thus, the growing interest in derma cosmetics can offer beneficial opportunities for industries to invest in the cosmetic market. This is one of the crucial opportunities for the cosmetic peptide manufacturing market.

Growing awareness of using active ingredients in cosmetics and the production of bioactive peptides with natural resources is increasing the global market demand. Researchers are utilizing biotechnology sources to synthesize bioactive peptides. These developments are aimed at increasing the production efficiency of the bioactive peptide with high-quality expectations.

According to a research study, it was found that biotechnology sources have been highly accepted. Thus, projecting opportunistic ideas for peptide synthesis over other sources. Consequently, opportunities are present in the market for manufacturers to invest in cosmetic peptide synthesis using biotechnology.

Country-wise insights

Countries	CAGR (2024 to 2034)
United States	5.7%
Germany	8.3%
United Kingdom	6.6%
Japan	6.5%
China	7.2%

Analysis of Key Factors Associated with the United States Market Growth

The United States dominates the North American market with a 94.6% market share in 2023. The United States is expected to exhibit a CAGR of 5.7% throughout the forecast period.

• Strong emphasis on skincare campaigns has significantly contributed to heightened awareness. This, in turn, is fostering an increased adoption of cosmetic products.
• Notably, dedicated campaigns, such as skin cancer awareness month in May, showcase commitment to educate public about skincare. Thus, driving demand for cosmetic ingredients.
• The United States is witnessing a notable surge in the development and manufacturing of active ingredients. Thereby, responding to the rising consumer demand for innovative skincare solutions.

All these factors are consolidating market position of the United States on the global scale.

Lucrative Opportunities Present for Manufacturers in China

In 2023, China held a dominant global revenue in the East Asian market and contributed around USD 19.82 million. The market is expected to record a CAGR of 7.2% over the forecast period.

China's cosmetic peptide manufacturing market is poised for lucrative opportunities, propelled by several factors. These include the country's burgeoning demand for beauty and skincare products, a rising middle-class population, and increased consumer awareness. Other key factors are as follows:

• The expanding middle-class population in China has higher disposable incomes, leading to an increased demand for premium cosmetic products.
• Increasing investments in research and development for cosmetic peptides in China are fostering innovation and driving the production of advanced skincare formulations.

Germany, an Emerging Market for Cosmetic Peptide Manufacturing

Germany occupies a 20.2% value share in Western Europe in 2023 and is expected to grow at a CAGR of 8.3% during the forecast period. Factors positioning Germany as a lucrative market for cosmetic peptide synthesis providers are as follows:

• Manufacturing of high-quality peptides in Germany.
• Presence of well-established companies with extensive experience in peptide synthesis.
• The country's position as a major cosmetics market in Europe.

These factors are contributing to Germany’s leadership in the cosmetic peptide manufacturing market. Germany is thus significantly supporting the global market share.

Key Players in the United Kingdom Serving Customers by Ramping Up their Production Capacity

The United Kingdom market is estimated to register a CAGR of 6.6% through 2034. Manufacturing of cosmetic peptides is rising in the country on account of the following factors:

• Leading companies and organizations within the country are joining hands to ramp up cosmetic peptide manufacturing. For instance, in 2023, Biosynth and Cambridge Research Biochemicals (CRB) collaborated to add a peptide production site. The development also enriched the company with an expertise of 40+ years in labeled, complex, and difficult-to-make peptides.
• Consumers in the United Kingdom are increasingly spending on products to enhance their appearance. In the midst of surging looks consciousness, consumers are seen purchasing cosmeceuticals containing synthetic peptides.

Increasing Geriatric Population in Japan Enhancing Prospects for Cosmetic Peptide Manufacturing

Japan has been assessed to showcase a positive outlook in the market for cosmetic peptide manufacturing over the coming decade. The country is anticipated to rise at a CAGR of 6.5% through 2034. Top factors contributing to this optimistic trajectory are as follows:

• Peptides are an excellent option for wound generation, skin-related anti-aging effects, and many other areas of interest. As a result, synthetic peptides are increasingly consumed as an active ingredient in cosmetics. Additionally, the high elderly population in Japan is another important factor that is contributing to a heightened uptake of products containing cosmetic peptides.
• Key players are focusing on the development of peptide-applied technologies. These include peptide and silicone hybrids, peptide derivatives, and ionic complexes using the chemical modification method. Continuous innovations and technological advancement in cosmetic peptide manufacturing is anticipated to fuel market growth.

Category-wise Insights

Insights into Key Products Stimulating Growth of the Cosmetic Peptide Manufacturing Market

Top Product	Signal Peptides
CAGR (2024 to 2034)	5.5%

The market value of signal peptides in cosmetic peptide manufacturing is USD 129.3 million, representing a sizable 55.3% market share in 2023. The segment is expected to grow at a CAGR of 5.5% over the forecast period.

Signal peptides lead the cosmetic peptide manufacturing market by product due to their several benefits, scientific credibility, and their ability to address key skincare concerns.

Ongoing demand for effective and advanced skincare solutions positions signal peptides as a pivotal ingredient in the development of innovative cosmetic products. Signal peptides play a crucial role in cellular communication, transmitting specific signals to cells to initiate processes like collagen synthesis and skin regeneration.

Anti-Aging Series Peptides Lead the Global Market by Application

Top Application	Anti-Aging Series Peptides
CAGR (2024 to 2034)	6.6%

The market value of the anti-aging series peptides in cosmetic peptide manufacturing is USD 62.95 million, representing a sizable share of 26.9% of the market in 2023. The segment is expected to record a CAGR of 6.6% during the forecast period.

The anti-aging series peptides application is leading in the cosmetic peptide manufacturing market due to its:

• Comprehensive anti-aging benefits.
• Promotion of collagen production.
• Support for skin regeneration.
• Versatility to be incorporated into various skincare products.

The scientific backing and alignment with consumer preferences for advanced skincare contribute to its prominence in the market.

Skin Care Products Leading the Global Market by End Product

End Product	Skin Care
CAGR (2024 to 2034)	5.5%

The skin care segment accounted for a market share of 53.1% in 2023. The segment is projected to exhibit a CAGR of 5.5% over the forecast period.

The skin care end-product segment is leading in the cosmetic peptide manufacturing market. This can be attributed to its versatility, anti-aging properties, targeted solutions, and daily use integration. Manufacturers are developing effective and innovative skincare solutions in alignment with consumer preferences.

Peptides' effectiveness in addressing a range of skincare concerns positions them as a key ingredient in the formulation of skin care products. Thus, driving the leadership of the skin care segment.

Cosmetic Manufacturers Leading the Global Market by End User

End User	Cosmetic Manufacturers
CAGR (2024 to 2034)	6.0%

Cosmetic manufacturers have a considerable presence in the cosmetic peptide manufacturing market, accounting for a share of 47.6% of the market in 2023. The segment is predicted to expand at a CAGR of 6% during the forecast period.

The cosmetic manufacturers' end-user segment leads in the cosmetic peptide manufacturing market. Cosmetic manufacturers drive innovation and product development. These manufacturers invest in research and development to create new formulations that leverage the benefits of peptides. Their commitment to innovation positions them at the forefront of introducing novel products to the market.

Key Players Raising the Market’s Value

The strategic combination of product launches and collaborations emerges as a robust and forward-thinking approach. Product launches signify innovation and responsiveness to evolving consumer needs. Thus, allowing companies to introduce cutting-edge formulations that leverage the latest advancements in peptide technology. These alliances enable cosmetic peptide manufacturers to access novel technologies, share expertise, and collectively contribute to groundbreaking developments.

Recent Developments

• In January 2022, BASF introduced Peptovitae™, an innovative series comprising four patented peptides that signify an advancement in the development of scientifically crafted biomimetic peptides.
• In April 2021, Sederma, a subsidiary of Croda, unveiled a novel peptide technology designed to re-educate the hair bulb, encouraging the production of its own authentic pigmentation. Simultaneously, this technology offers heightened protection against both intrinsic and extrinsic oxidative damage.
• In March 2020, DSM developed a completely new small cosmetic peptide ingredient SYN-GLOW™. The ingredient has exceptional efficacy on human skin.

Leading Companies in Cosmetic Peptide Manufacturing Market

• Croda International Plc
• Ashland
• DSM [Koninklijke DSM NV]
• Bachem
• Genscript Biotech Corp
• BASF SE
• Geltor
• The Lubrizol Corporation
• Symrise
• Bio basic Inc.
• Regeron Inc.
• Merck KGaA
• RS Synthesis, LLC
• CSBio Company Inc.
• Creative Peptides
• Spec Chem Industry Inc.
• LipoTrue, SL
• Fibroheal
• Seiwa Kasei Co., Ltd.
• Silab
• Others

Key Market Segments Covered in Cosmetic Peptide Manufacturing Market Report

By Product:

• Signal Peptides
• Neurotransmitter Inhibitors
• Carrier Peptides
• Enzyme Inhibitor Peptides
• Structural Peptides
• Synthetic Antimicrobial Peptides (Amps)
• Others

By Application:

• Hair/Eyelash/Eyebrow Care Series Peptide
• Whitening Series Peptides
• Anti-Aging Series Peptides
• Skin Renewal Series Peptides
• Anti-allergic and Anti-Inflammatory Series Peptide
• Slimming and Breast Enhancement Peptides
• Others

By End Product:

• Skin Care
  • Creams and Moisturizers
  • Sunscreen lotions
  • Serums
• Hair Care
  • Creams
  • Serums
• Eye Care
  • Creams
  • Serums

By End User:

• Cosmetic Manufacturers
• Cosmetic Contract Manufacturers
• Biopharmaceutical Industries (Personal care)

By Region:

• North America
• Latin America
• East Asia
• South Asia and Pacific
• Western Europe
• Eastern Europe
• Central Asia
• Russia and Belarus
• Balkan and Baltic Countries
• Middle East and Africa

Frequently Asked Questions

How Big is the Cosmetic Peptide Manufacturing Market?

The global market value is set to reach USD 244.2 million in 2024.

At What Rate will the Global Market Rise through 2034?

Global cosmetic peptide manufacturing demand is anticipated to rise at 5.4% CAGR through 2034.

What is the Expected Market Size by 2034?

The global cosmetic peptide manufacturing market is expected to reach USD 411.9 million by 2034.

Which End Product Holds Significant Market Share?

The skin care segment holds a significant share of the market.

Which End User Significantly Utilizes Cosmetic Peptides for Product Manufacturing?

Cosmetic manufacturers are the leading end users in the market.